Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Natalia Luque‐Caro"'
Autor:
Carmen González‐Olmedo, Francisco José García‐Verdejo, Antonio Reguera‐Teba, Carmen Rosa‐Garrido, José Antonio López‐López, Leticia Díaz‐Beltrán, Patricia Mena García, Natalia Luque‐Caro, Fernando Gálvez‐Montosa, Ana Laura Ortega‐Granados, María Ruiz‐Sanjuan, Antonio Cózar‐Ibáñez, Juan Sainz, Juan Antonio Marchal, José Camacho, José Pérez delPalacio, Rosario Fernández‐Godino, Caridad Díaz, Pedro Sánchez‐Rovira
Publikováno v:
Clinical and Translational Medicine, Vol 14, Iss 1, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/7b4ca450c8c744ecbc50aea1cb5911cf
Publikováno v:
Journal of Gastrointestinal Oncology. 14:692-704
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0939ef095fb01ce916c073166ae408a
https://doi.org/10.21037/jgo-22-517
https://doi.org/10.21037/jgo-22-517
Human Plasma Metabolomics for Biomarker Discovery: Targeting the Molecular Subtypes in Breast Cancer
Autor:
Ariadna Martín-Blázquez, José Pérez del Palacio, Leticia Díaz-Beltrán, Pedro Sánchez-Rovira, Fernando Gálvez-Montosa, Mónica Fernández-Navarro, Carmen González-Olmedo, Ana Laura Ortega-Granados, Natalia Luque-Caro, Caridad Díaz, Francisca Vicente
Publikováno v:
Cancers, Vol 13, Iss 147, p 147 (2021)
Cancers
Volume 13
Issue 1
Cancers
Volume 13
Issue 1
Purpose: The aim of this study is to identify differential metabolomic signatures in plasma samples of distinct subtypes of breast cancer patients that could be used in clinical practice as diagnostic biomarkers for these molecular phenotypes and to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c876f4dc761b26afbf116ab0c6c73385
https://pubmed.ncbi.nlm.nih.gov/33466323
https://pubmed.ncbi.nlm.nih.gov/33466323
Autor:
Pedro Sánchez-Rovira, Carmen Herrero-Rodríguez, Leticia Díaz-Beltrán, Celia Lacárcel-Bautista, María Ángeles Duro-Fernández, Manuel Ruiz-Bailén, Juan Francisco Marín-Pozo, Ana Laura Ortega Granados, Luis Yaguez-Mateos, Gaspar Jesús Duro-Ruiz, Javier García-Alegría, Gerardo Pérez-Chica, Francisco García-Verdejo, Maria Isabel Sierra-Torres, Mónica Fernández-Navarro, Josefa A. Aguilar-García, Natalia Luque-Caro, Agustín Rodríguez-Sánchez, Fernando Gálvez-Montosa, Cristina Quero-Blanco
Publikováno v:
SSRN Electronic Journal.
Background: The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2, keeps spreading globally. Evidence suggests that a subgroup of patients with severe symptomatology might have cytokine storms, wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c142887b88902c2727ba46f202851f36
https://doi.org/10.2139/ssrn.3666155
https://doi.org/10.2139/ssrn.3666155
Autor:
A. García-Palomo, Pedro Sánchez Rovira, Ana Lopez-Gonzalez, Maria del Mar Muñoz Sánchez, Natalia Luque Caro, María José Molina Garrido, Maria del Carmen Soriano Rodríguez, Maria Yéssica Plata Fernández, Laura López-González
Publikováno v:
Future Oncology. 14:5-12
Numerous patient- and disease-related factors must be considered when deciding a treatment approach for hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2−) metastatic breast cancer. Hormone therapy (HT) is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1dd251792ea1b7afbf8ac26cdd3bb02e
https://doi.org/10.2217/fon-2017-0355
https://doi.org/10.2217/fon-2017-0355
Autor:
Natalia Luque Caro, David Fernández Garay, Complejo Hospitalario de Jaén, Fernando Gálvez Montosa
Publikováno v:
ACTUALIDAD MEDICA. 102:180-182
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b87d94aa584804298eb05ed432837b0e
https://doi.org/10.15568/am.2017.802.ao01
https://doi.org/10.15568/am.2017.802.ao01
Autor:
Maria Del, Mar Muñoz Sánchez, Maria Del, Carmen Soriano Rodríguez, Maria José, Molina Garrido, Ana, López-González, Andrés, García-Palomo, Laura, López-González, Maria Yéssica, Plata Fernández, Natalia Luque, Caro, Pedro Sánchez, Rovira
Publikováno v:
Future oncology (London, England). 14(7s)
Numerous patient- and disease-related factors must be considered when deciding a treatment approach for hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer. Hormone therapy (HT) is ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b562c74a4a1cf1175d0aec459ed36126
https://pubmed.ncbi.nlm.nih.gov/29611755
https://pubmed.ncbi.nlm.nih.gov/29611755
Autor:
Miguel Angel Moreno Jimenez, Mónica Fernández Navarro, Carmen Garrido, Ana Laura Ortega Granados, Juan Francisco Marín Pozo, Nuria Cárdenas Quesada, Pedro Sánchez Rovira, Francisco José García Verdejo, Natalia Luque Caro, Capilla de la Torre Cabrera, María Ruiz Sanjuan
Publikováno v:
Journal of Thoracic Oncology. 12:S917-S918
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d79f448f5cabe89032dd3576bf29683e
https://doi.org/10.1016/j.jtho.2016.11.1257
https://doi.org/10.1016/j.jtho.2016.11.1257
Autor:
Francisco José García Verdejo, David Fernández Garay, Mónica Fernández Navarro, Ana Laura Ortega Granados, Pedro Sánchez Rovira, Juan Francisco Marín Pozo, Nuria Cárdenas Quesada, Miguel Angel Moreno Jimenez, Capilla de la Torre Cabrera, María Ruiz Sanjuan, Carmen Garrido, Natalia Luque Caro
Publikováno v:
Journal of Thoracic Oncology. 12:S700-S701
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef9f030cabf9478034428272f7d72419
https://doi.org/10.1016/j.jtho.2016.11.920
https://doi.org/10.1016/j.jtho.2016.11.920
Autor:
Capilla de la Torre Cabrera, Ana Laura Ortega Granados, Juan Francisco Marín Pozo, Nuria Cárdenas Quesada, Carmen Tirado Bejarano, Mónica Fernández Navarro, Natalia Luque Caro, Francisco José García Verdejo, Facundo Alberti Vargas, Miguel Angel Moreno Jimenez, María Ruiz Sanjuan, Pedro Sánchez Rovira
Publikováno v:
Journal of Clinical Oncology. 36:e18032-e18032
e18032Background: All patients diagnosed of advanced or relapsed squamous cell carcinoma of head and neck (SCCHN) are relapsing before a platin-based first line therapy, and then, median overall su...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb8a9af3ed5b71ded40c7b2fcf74977d
https://doi.org/10.1200/jco.2018.36.15_suppl.e18032
https://doi.org/10.1200/jco.2018.36.15_suppl.e18032